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Abstract: The aim of this study was to investigate the influence of the long-term treatment of rats with letrozole
on the testis morphology. The pharmacologically induced estrogen deficiency caused statistically significant
decreases of both intratesticular and serum levels of estradiol, and morphological changes in the seminiferous
epithelium and in the interstitial tissue of the testes. Six months of treatment resulted in the sloughing of prema-
ture germ cells of the seminiferous epithelium into the tubular lumen and in intraepithelial vacuolization. Multi-
nucleated giant cells composed of premature germ cells, conglomerates of various cell nuclei and cell debris as
well as irregularities and infoldings of the tubular basement membrane were also seen. Moreover, deep invagi-
nations of the lamina propria with myoid cells were observed. Cells in the interstitial tissue showed changes
similar to that observed in aging processes. The cytoplasm of LH-R-positive Leydig cells was loaded with lipo-
fuscin granules. The number of lipofuscin-loaded cells was significantly increased in the interstitial tissue of
testis in letrozole-treated rats. The results indicate the direct influence of estrogens on seminiferous tubules and
the interstitial tissue morphology. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 4, pp. 677–684)
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Introduction
The testis performs two essential functions: the pro-
duction of spermatozoa in the spermatogenesis pro-
cess and the synthesis of steroids in interstitial Ley-
dig cells, involved in the secretion of testosterone and
other steroids including estrogens [1]. The major en-
docrine regulators of testis functions are gonadotro-
pins. Luteinizing hormone stimulates synthesis and
secretion of testosterone in Leydig cells that express
LH receptors (LH-R). FSH targets Sertoli cells to
stimulate their function to maintain the spermatoge-
nesis. Today it is known that  as well as androgens,
estrogens are also included in the regulation of sper-
matogenesis, spermatozoa differentiation and nor-
mal fertility [2–7]. Treatment with estradiol induces
spermatogenesis in hypogonadal mice congenitally
lacking gonadotropin and thus, sex steroid produc-
tion [8–10]. Furthermore, estrogens prevent apop-
tosis of germ cells within human seminiferous tu-
bules in vitro [11].
Estrogens are formed from androgens in the re-
action catalyzed by cytochrome P450 aromatase
(P450arom). The key enzyme for estrogens biosyn-
thesis is responsible for irreversible aromatization of
androstenedione and testosterone into estrogens
[12, 13]. P450arom is the member of the cytochrome
P450 gene superfamily, and is a product of transcrip-
tion of a single copy of the Cyp19 gene. In humans,
this is located on chromosome 15 [13–15], in rats on
chromosome 8, and in mice on chromosome 9 [16].
The enzyme is a microsomal complex composed of two
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proteins: specific heme-glycoprotein cytochrome P450
aromatase, which contains a steroid binding pocket,
and ubiquitous NADPH-cytochrome P450 reductase
[13, 14]. It is known that aromatase is widely distrib-
uted in the testes of mammals, including humans
[14, 15]. In adult men, transcripts of aromatase are
found in Leydig cells and Sertoli cells [13]. Latest stud-
ies have proved that human and animal germ cells
within the seminiferous epithelium also have the abil-
ity to convert androgens into estrogens [14, 17]. In
the seminiferous epithelium of adult rats, P450arom
transcripts have been detected in spermatocytes and
spermatids, while the enzyme activity was more intense
in haploid germ cells, especially in the elongated sper-
matids [13]. Additionally, the presence of P450arom has
been found in animal spermatozoa [18] and ejaculated
spermatozoa from healthy men, with stronger intensity
in the cells containing cytoplasmic droplets [14].
Estrogens exert their cellular effects via estrogen
receptors (ERs) widely distributed throughout the
male genital tract [13]. The importance of estrogen
in the male reproductive system is supported by re-
ports of testicular anomalies in men with mutations
in aromatase gene and lacking a functional ERa
[19–22], and studies of mice that lack a functional ar-
omatase gene (ArKO) or a- and b-estrogen recep-
tors (aERKO and b ERKO) [23].
The aim of this present study was to investigate
the effect of long-term (six months) estrogen defi-
ciency on the testis morphology in adult male rats. To
produce the estrogen deficiency, we used letrozole,
a non-steroidal inhibitor of P450arom, which inhibits
the enzyme by reversible competition.
Material and methods
The studies were performed on three-month old sexually
mature male Wistar rats. The rats were maintained under
standard conditions of lighting (12L:12D) and nutrition. The
animals were randomly divided into a control group and an
experimental group (six rats per group). The rats in the ex-
perimental group received per os letrozole (Femara®; No-
vartis Pharma, Germany) — non-steroidal inhibitor of cy-
tochrome P450 aromatase (P450arom) at a dose of 1 mg/kg
b.w./day for six months. After the treatment, animals were
sacrificed under Thiopental (Biochemie GmbH, Austria)
anesthesia (120 mg/kg b.w., i.p.). Then the testes were im-
mediately taken, fixed in Bouin’s fluid and embedded in
paraffin. For the morphological analysis, serial sections of
testes were stained with PAS methods, toluidine blue and
van Gieson [24].
The number of cells with lipofuscin granules was esti-
mated in ten randomly chosen areas of interstitial tissue in
the gonads of control and letrozole-treated rats.
Immunohistochemical study. To identify Leydig cells in the
interstitial tissue, we carried out an immunohistochemical
(IHC) reaction with specific anti-LH-R antibody (Santa
Cruz Biotechnology, Santa Cruz, CA, USA; cat. no.
sc-25828; final dilution 1:100). The deparaffinized sections
were microwaved in citrate buffer (pH 6.0) for heat-induced
epitope retrieval. After slow cooling to room temperature,
the slides were washed in PBS twice for 5 min and then
incubated for 60 min with primary anti-LH-R antibody.
Next, one part of the slides were stained using the avidin–
–biotin–peroxidase system with diaminobenzidine as the chro-
mogen (EnVision+System-HRP (DAB); Code K4010 Dako-
Cytomation, Glostrup, Denmark) in accordance with the
manufacturer’s staining protocol. The sections were washed
in distilled H2O and counterstained with hematoxylin. As
a negative control, the specimens were processed in the ab-
sence of the primary antibody. Positive staining was defined
by visual identification of brown pigmentation using a light
microscope.
Following primary antibody incubation, the second part
of the slides were incubated with biotinylated secondary anti-
-rabbit antibody from goat (Vector Laboratories, Burlin-
game, CA, USA; cat. no.: BA-1000) at final dilution 1:100
for 30 min. The last step of the reaction was the treatment
of slides with Alexa Fluor-streptavidin complex (streptavi-
din, Alexa Flour® 488 conjugate, Molecular Probes, Eugene,
OR, USA; cat. no.: S11223) at a final dilution 1:50 for 30
min. PBS-washed sections were evaluated using a confocal
microscope (FV500, Olympus, Germany). Moreover, de-
paraffinized and unstained slides of rat testes were estimat-
ed in fluorescent microscopy (Zeiss, Axioscop, Germany)
to detect the autofluorescence of a lipofuscin.
Hormone levels. In the blood serum of the control and
letrozole-treated rats, the concentration of 17b-estradiol
(E2) was determined using the electroluminescence (ECLIA
— Electrochemiluminescence Immunoassay) method (Co-
bas 6000 analyzer, Roche, Switzerland). Some of the sam-
pled testes were used to prepare tissue homogenates. The
tissues, frozen in liquid nitrogen, underwent homogeniza-
tion using a hammer mill, then equal volumes of tissues were
sampled, placed in 500 μL 0.9% NaCl and homogenized
using CAT X120 homogenizer (Germany). The homoge-
nates were centrifuged for 10 min at 12,000 G at 4°C. Su-
pernatants were used to determine the estradiol level.
Ethical issue. The experiment was conducted in full accor-
dance with Polish law and with the approval of the ethics
committee of the Pomeranian Medical University (Szcze-
cin, Poland; approval no. BN-05/07).
Statistical analysis. Results are expressed as median (M),
lower and upper quartile (Q1–Q3). Nonparametric Mann–
–Whitney U test was used to check significance of differenc-
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es between experimental and control groups. The value of
p < 0.05 was considered to indicate statistically significant
differences. The normality test has been performed by Sha-
piro–Wilk test. Calculations were done using the software
package Statistica 6.1.
Results
Hormone levels
The level of E2 in the blood of rats receiving letrozo-
le (31.2 ± 12.29 pg/mL) was significantly (p < 0.05)
lower than in the control (54.74 ± 8.72 pg/mL).
A significant difference in intratesticular E2 concen-
tration was also found between the experimental
(20.94 ± 5.15 pg/mL) and control rats (40.54 ± 4.43
pg/mL) (p < 0.001) (Table 1).
Morphology of testis
The testis of control rats presented the normal mor-
phology. The seminiferous epithelium contained all
generations of the germ cells, corresponding to the
stages of the seminiferous epithelium cycle (Figure 1A).
The chronic treatment of rats with letrozole resulted
in the morphological changes in the seminiferous
epithelium. Some tubules showed the disorganization
of the seminiferous epithelium. In the lumen of the
tubules in experimental rats, the clusters of sloughed
germinal cells, including spermatids and late
pachytene spermatocytes were observed (Figure 1B,
red arrow). Discontinuous germ cell layers forming
the irregular intercellular spaces as the effect of the
premature germ cells sloughing (Figure 1B, black ar-
rows) were also noticed. Moreover, intraepithelial
vacuoles of varying sizes in the basal region of the
seminiferous epithelium were found (Figure 1C, black
arrows). In gonads of rats chronically treated with
letrozole, tubules with multinucleated giant cells, con-
taining nuclei of spermatogonia and spermatocytes
within the seminiferous epithelium (Figure 1D, red
arrows) were detected. Additionally, conglomerates
with difficult to identify degenerating cells were ob-
served. The conglomerates contained dividing cells,
vacuoles, and leukocytes. Cell debris and sloughed
germ cells were visible in the lumen of some seminif-
erous tubules (Figure 1E). In some cases, the peritu-
bular wall of seminiferous tubules seemed to be af-
fected. There were tubules with curvatures and irreg-
ularities of the wall (Figures 2D, E, black arrows) and
infolding of the basement membrane toward the se-
miniferous tubule lumen. The invaginations were of
various lengths or depths directed into the center of
the lumen. Finally, invaginations of the limiting mem-
brane with the presence of flat and elongated myoid
cells were noticed (Figure 2F, yellow arrow).
The morphological changes were observed also in
the interstitial tissue. The cells with strong PAS-posi-
tive material were observed in the interstitial tissue
of testes, both in control (Figure 2A) and experimen-
tal (Figure 2B) rats. The number of the cells was in-
creased in gonads of letrozole-treated rats (Figure 2B,
black arrows) compared to gonads of control rats
(Figure 2A, black arrow). To confirm the observation,
staining with toluidine blue was carried out. It showed
the cells with brown-yellow material (Figure 2C, red
arrows). In our opinion, both PAS-positive cells and
toluidine blue-stained cells were loaded with lipofus-
cin. Therefore, deparaffinized sections of testes with-
out staining were estimated under fluorescent micros-
copy, taking into account the lipofuscin property to
autofluorescence. The orange-red fluorescence was
found in interstitial cells of experimental rats (Figure 3B,
red arrows). There was no autofluorescence in cells
of the seminiferous epithelium (Figure 3A). How-
ever a few cells in the interstitial tissue showed au-
tofluorescence in control rat testis. The lipofuscin was
not uniformly distributed in the cytoplasm of cells
Table 1. The concentration of 17b-estradiol (E2) in the serum and testis homogenates of control rats and rats treated with
letrozole
Serum Testes
Estradiol (E2) [pg/mL] Estradiol (E2) [pg/mL]
Control (C) Letrozole Control Letrozole
n = 5 n = 5 n = 5 n = 5
M 55.32 28.2 40.1 22.9
Q1–Q3 53.7–56.7 25.63–38.49 38.1–42.39 18.2–23.93
X ± SD 54.74 ± 8.72 31.2 ± 12.29 40.54 ± 4.43 20.94 ± 5.15
vs. C* vs. C**
M — median; Q1–Q3 — lower–upper quartiles; X ± SD — mean ± SD; vs. — versus; asterisks indicate statistically significant differences in
Mann–Whitney U test: *p < 0.05, **p < 0.01
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Figure 1. Cross-sections of seminiferous tubules of the testes in control (A), and experimental (B–E) rats. All germ cells generations are present,
suitable for each cycle (II and VII) in the seminiferous epithelium of tubules in control rats. The sloughed premature germ cells in the lumen of
tubule (red arrow) and empty areas (black arrows) after sloughed cells in the seminiferous epithelium in XIV stage of the cycle (B), the vacuoliza-
tion of the seminiferous epithelium (C), multinucleated giant cells (red arrows) (D) in the seminiferous epithelium and conglomerates containing
dividing cells, vacuoles, leukocytes (black arrow) in the lumen of tubule of experimental rats (E). PAS: A–C; van Gieson method: D, E.
Scale bars = 100 μm (A); 50 μm (B, C); 20 μm (D, E)
Figure 2. PAS-positive lipofuscin-containing cells in the interstitial tissue of testes in control rats (black arrows) (A) and letrozole-treated rats
(black arrows) (B) and cells with lipofuscin stained with toluidine blue (red arrows) (C). Shallow (D, E) (red arrows) and deep invaginations of
limiting membrane (black arrows) (F). Note the presence of nucleus of myoid cell (yellow arrow) (F). PAS: A, B, D–F; toluidine blue: C.
Scale bars = 50 μm (A, B); 20 μm (C–F)
and appeared in the form of granules of various siz-
es. The nucleus of the cells was eccentrically located.
To distinguish if the lipofuscin-accumulating cells
were really Leydig cells, the immunoexpression of LH
receptors was performed. The cells with peripherally
located nuclei displayed LH-R expression, both in
control (Figures 4A, B) and experimental rats (Fig-
ures 4C–E) interstitial tissues. Additionally, the co-
localization of red autofluorescence of lipofuscin and
green fluorescence of LH-R was estimated. The or-
ange fluorescence, indicating co-localization of lipo-
fuscin and LH-R in the same cells was observed in
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the interstitial tissue of the control (Figure 3C, or-
ange arrows) and in the experimental (Figure 3D,
orange arrows) rats.
Figure 3. Cross-sections of seminiferous tubules of the testes in
control (A, C), and experimental (B, D) rats. No cells with autofluore-
scence of lipofuscin (A) and presence of autofluorescence of lipofuscin
(C, red fluorescence, red arrow) in a few cells in the interstitial tissue
in control rat testes. Presence of autofluorescence of lipofuscin (red
arrows) in the interstitial cells in experimental rats (B). Co-localization of
orange autofluorescence (orange arrows) of lipofuscin (red fluorescence,
red arrow) and LH-R (green fluorescence, green arrow) in the cytoplasm
of Leydig cells in testes of control (C) and experimental (B, D) rats.
Scale bars = 50 μm (A–D)
Figure 4. Immunolocalization of LH-R in Leydig cells of control (A, B) and experimental rats (C–E) (black arrows). LH-R immunoreactivity with
strong intensity in the cytoplasm of Leydig cells (black arrows) in the interstitial tissue of the testes in control and experimental rats. IHC.
Scale bars = 50 μm (A–E)
The number of interstitial cells with lipofuscin
granules in testes of experimental rats was significantly
higher in both PAS- and toluidine blue stained slides
(26.0 ± 14.17 and 25.8 ± 9.66, respectively) compared
to control rats (6.5 ± 3.17 and 3.3 ± 2.9, respective-
ly). The differences were statistically significant:
p < 0.001 (Table 2).
Discussion
In the present study, the effect of long-term estrogen
deficiency on the testis morphology in adult male rats
was investigated. The testicular anomalies observed
by us confirmed an essential role of estrogens for
normal testicular function. To produce the estrogen
deficiency in male rats, we used letrozole — a third-
-generation inhibitor of aromatase. The letrozole struc-
ture provides a good fit with the substrate-binding site
and additionally co-ordinates with aromatase heme
iron and effectively inhibits the hydroxylation —
a reaction necessary for aromatization [25]. Because of
the ability of letrozole to reduce serum estradiol con-
centration, it is usually used in the treatment of es-
trogen-sensitive breast cancer in women [26–28].
However, it is also used as a first-line treatment in
hormone-sensitive male breast cancer [29, 30], and
in prepubertal boys to improve final growth [31, 32].
Literature data indicates that chronic treatment
with P450arom inhibitor can lead to dysregulation of
testes weight, serum and intratesticular gonadotro-
pins as well as testosterone levels [33, 34]. The aro-
A B
C D
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matase inhibition also affected sperm production, as
has been evidenced in boars by At-Taras [35].
The levels of circulating and intratesticular es-
tradiol were significantly decreased (43% and 48%,
respectively) in letrozole-treated rats in our experi-
ment. The long-term estrogen deficiency resulted in
the morphological alternations of the seminiferous
tubules and the interstitial Leydig cells in rat gonads.
The presence of immature germ cells in the lumen
of many seminiferous tubules was observed. Addi-
tionally, within the seminiferous epithelium, the
empty spaces after sloughing premature germ cells
were present.
The obtained results indicated that long-term es-
trogen deficiency produced the disruption of the ad-
hesion between Sertoli cells and germ cells, and
caused premature loss of germ cells. The sloughing
of premature germ cells from the seminiferous epi-
thelium was observed in our former studies with dis-
turbances of hormonal balance caused by the inhibi-
tion of 5a-reductase, that decreased DHT level [36]
and in rats treated with soya isoflavones, that in-
creased estradiol level [37]. Similar effects have been
observed in testes of Calomys callosus chronically
treated with ethanol as a result of testosterone level
reduction [38] or in testes of adult rats treated with
cimetidine referred as antiandrogenic agent [39]. The
data indicates that germ cells sloughing is not a spe-
cific process and can be found in different hormonal
disturbances.
In our study, the chronic estrogens deficiency
caused other kinds of abnormalities such as the in-
traepithelial vacuolization and the formation of multi-
nucleated giant cells. Similar changes have been ob-
served by others in the testes of mice and rats after
treatment with antispermatogenic agents, for instance
20,25-diazacholesterol dihydrochloride, nitrofurazone
or gossypol tetra-acetic acid [40, 41], antineoplastic
agents or low doses of cadmium [42, 43]. As was men-
tioned by Hoffer [40], the mechanism of formation
of inter- and intracellular vacuolization is not known.
However, the intracellular vacuolization observed in
that study arose from swelling of agranular reticulum
elements and subsurface cisternae. To explain the for-
mation of intraepithelial vacuoles observed in our
study, a more detailed examination on the molecular
level is needed.
Germ cells loss by apoptosis and therefore multi-
nucleated giant cells occur normally during spermato-
genesis [44–46]. The number of cells in the seminif-
erous tubules is determined by a dynamic balance
between cells proliferation and apoptotic cell death.
Any imbalance of the two processes may result in his-
tological changes in the seminiferous epithelium [47],
including the increased number of multinucleated
giant cells.
The testicular alternations as germ cell sloughing,
intraepithelial vacuolization, and the presence of
multinucleated giant cells were accompanied with ir-
regulation and folding of the limiting membrane and
its deep invaginations into the seminiferous tubules.
In some cases, the membrane was separated from the
seminiferous epithelium and seemed to be disrupt-
ed. Similar invaginations were observed for the first
time by Haider et al. [48] in the testes of patients with
varicocele. They suggested that the basement mem-
brane and the innermost one or two myoid cell layers
participated in the formation of invaginations [48].
The invaginations observed in testis of experimental
rats in our study contained one layer of myoid cells.
The irregularities, infolding of the basement mem-
brane, lamellation of the lamina densa, as well as hy-
perplasia of collagen fibers of the tunica propria have
been described in alcohol-fed Sprague Dawley rats,
in which testosterone levels in serum and testes de-
clined [49]. A similar effect was observed in the tes-
tes of rats injected with etoposide (VP-16) used as
a form of chemotherapy [50]. The basement membrane
is modified extracellular matrix [51], coexisting side-
-by-side with anchoring junctions, such as ectoplasmic
specializations and desmosome-like junctions [52–54].
Sertoli cells and germ cells at different stages of dif-
ferentiation are resting on the membrane, which plays
a significant role in the spermatogenesis regulation
Table 2. The number of interstitial cells with lipofuscin granules in slides stained with PAS method and toluidine blue
PAS Toluidine blue
n = 10 n = 10
Control (C) Letrozole Control Letrozole
M 5.5 22 3.5 23.0
Q1–Q3 4.0–9.0 17.0–30.0 0.0–6.0 17.0–37
X ± SD 6.5 ± 3.17 26.0 ± 14.17*** 3.3 ± 2.9 25.8 ± 9.66***
vs. C vs. C
M — median; Q1–Q3 — lower–upper quartiles; X ± SD — mean ± SD; n = 10 areas of the interstitial tissue; vs. — versus; asterisks indicate
statistically significant differences in Mann–Whitney U test: ***p < 0.001
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and maintenance of the function and dynamic of the
blood-testis barrier [52–54]. It can be supposed that
the invaginations observed in the testes of experimen-
tal rats could affect the functions of the seminiferous
epithelium caused by blood-testis barrier damage.
Additionally, we observed changes in the struc-
ture of interstitial cells. The interstitial cells of letro-
zole-treated rats were rich in lipofuscin granules. The
number of lipofuscin-loaded cells was significantly
higher than in the interstitial tissue of control rats.
Lipofuscin is often called age pigment and is consid-
ered to be a hallmark of aging [55]. The aging pro-
cess includes thickening, widening and hernia-like
protrusions of the basal membrane of seminiferous
tubules, and the increase of lipofuscin deposits in
Leydig cells [56]. Lipofuscin can be demonstrated by
staining with periodic acid-Schiff (PAS-method) or
utilizing an important property of lipofuscin — au-
tofluorescence [55]. Lipofuscin is most often found
in post-mitotic cells, including Sertoli cells, Leydig
cells and also macrophages [57]. The interstitial tis-
sue of the testis consists of loose connective tissue
with blood and lymphatic vessels, fibrocytes, macroph-
ages and clusters of Leydig cells. To identify the pop-
ulation of cells accumulating lipofuscin granules in
the interstitial tissue, we carried out an IHC reaction
for LH-R. Many interstitial cells with lipofuscin gran-
ules were identified as LH-R-positive Leydig cells.
It has been shown that Leydig cells in human ag-
ing testes accumulate lipofuscin granules. The cells
were regarded as dedifferentiated cells in which the
steroidogenic function is diminished [58]. Similar
observations have been obtained in mouse aging tes-
tes, where in the cytoplasm of both macrophages and
Leydig cells, lipofuscin granules were located. The
progressive accumulation of lipofuscin granules re-
sulted in the reduction of cytoplasmic organelles and
finally their absence in the cytoplasm of the cells [59].
In our study, not all cells accumulating lipofuscin in
the interstitial tissue can be classified as LH-R-posi-
tive Leydig cells. However, in the cells the expression
of LH-R could be decreased because of the dimin-
ished steroidogenic activity. Additionally, the pres-
ence of macrophages with lipofuscin granules in the
cytoplasm cannot be excluded.
In summary, long-term (six month) estrogen defi-
ciency produced histomorphological changes in rat
testes similar to that observed in the aging processes.
They included the sloughing of premature germ cells,
the vacuolization of the seminiferous epithelium, the
formation of giant cells and conglomerates of degen-
erating cells, shallow and deep invaginations of base-
ment membrane, as well as lipofuscin accumulation
in Leydig cells. These results demonstrate the impor-
tant role of estrogens on seminiferous tubules and
the interstitial tissue morphology.
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